J&J | JNJ - Trade Creditors


J&J reported $9.22B in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Abbott USD 4.68B 439M Mar/2026
Amgen USD 2.86B 16.65B Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Baxter International USD 1.03B 52M Jun/2026
Bayer EUR 6.59B 496M Mar/2026
Becton, Dickinson and Co. USD 6.11B 173M Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
Boston Scientific USD 1.23B 90M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
CONMED USD 101.02M 4.4M Jun/2026
Cooper Companies USD 233.3M 7.5M Mar/2026
Dexcom USD 2.08B 134.8M Jun/2026
Edwards Lifesciences USD 210.5M 29.4M Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Globus Medical USD 106.94M 3.28M Jun/2026
Insulet USD 123.3M 26.5M Jun/2026
Integra LifeSciences USD 82.64M 5.31M Jun/2026
Intuitive Surgical USD 1.92B 66.6M Jun/2026
J&J USD 9.22B 1.24B Jun/2026
Medtronic USD 2.57B 12M Dec/2025
Merck USD 3.83B 36M Jun/2026
Merit Medical Systems USD 70.74M 2.88M Jun/2026
Novartis USD 4.26B 64M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
Stryker USD 1.59B 207M Mar/2026
Tandem Diabetes Care USD 64.13M 4.27M Jun/2026
Teva Pharmaceutical Industries USD 2.72B 125M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026
Zimmer Biomet Holdings USD 352.4M 8.8M Jun/2026
Zoetis USD 452M 55M Jun/2026